MeSH term
Frequency | Condition_Probility | Aged | 2 | 0.0 |
Humans | 49 | 0.0 |
Animals | 28 | 0.0 |
Cell Line | 7 | 0.0 |
Comparative Study | 7 | 0.0 |
Mice | 8 | 0.0 |
Peptidyl-Dipeptidase A/*metabolism | 2 | 2.0 |
Rats | 5 | 0.0 |
Severe Acute Respiratory Syndrome/virology | 2 | 100.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Species Specificity | 2 | 0.0 |
Amino Acid Sequence | 11 | 0.0 |
Carboxypeptidases/*metabolism | 7 | 46.0 |
Catalysis | 3 | 0.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Hydrolysis | 4 | 0.0 |
Kinetics | 4 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
SARS Virus/*genetics | 2 | 40.0 |
Carboxypeptidases/*physiology | 2 | 50.0 |
Case-Control Studies | 2 | 0.0 |
Female | 5 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 3 | 0.0 |
Base Sequence | 4 | 0.0 |
Cercopithecus aethiops | 4 | 0.0 |
Gene Expression | 2 | 0.0 |
Vero Cells | 4 | 1.0 |
Carboxypeptidases/chemistry/*genetics/metabolism | 2 | 66.0 |
Sequence Alignment | 6 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Angiotensin I/metabolism | 2 | 9.0 |
Angiotensin-Converting Enzyme Inhibitors/pharmacology | 4 | 5.0 |
Binding Sites | 4 | 0.0 |
CHO Cells | 3 | 0.0 |
Cricetulus | 2 | 0.0 |
Hamsters | 4 | 0.0 |
Substrate Specificity | 8 | 0.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Adult | 3 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Gene Library | 3 | 0.0 |
Kidney/*enzymology | 2 | 2.0 |
Testis/enzymology | 2 | 3.0 |
Transfection | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Renin-Angiotensin System/*physiology | 2 | 3.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Genotype | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Immunohistochemistry/methods | 3 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Tissue Distribution | 4 | 0.0 |
Carboxypeptidases/chemistry/genetics/*metabolism | 2 | 66.0 |
Mutation | 2 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Receptors, Virus/*metabolism | 2 | 2.0 |
Solubility | 2 | 0.0 |
SARS Virus/*metabolism | 3 | 100.0 |
Myocardium/enzymology | 3 | 3.0 |
Peptidyl-Dipeptidase A/*genetics | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Angiotensin II/physiology | 2 | 8.0 |
Membrane Glycoproteins/*chemistry | 2 | 6.0 |
Viral Envelope Proteins/*chemistry | 2 | 66.0 |
Molecular Weight | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Up-Regulation | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
